Theoretically, by activating the activity of Sirt4 with small molecule drugs, it may be possible to calibrate the uncontrolled mitochondrial autophagy in sepsis, restore it to a protective level, and stabilize the kinetic balance, thereby protecting hepatocytes and even other organ cells from damage and improving the prognosis of patients. The gene discussed is SIRT4; the disease is Sepsis.